Prothena Corp Plc (PRTA)-Medical Equipment-Deals and Alliances Profile
April 2017
32
About the Report
About the Report
Prothena Corp Plc (Prothena) is a late stage clinical biotechnology company that discovers, develops and markets novel antibodies that are indicated for the treatment of diseases associated with amyloid or cell adhesion. The company concentrates on monoclonal antibodies directed specifically at disease-causing proteins. Its pipeline products comprise PRX002, indicated for the treatment of Parkinson's disease; NEOD001, indicated for the treatment of primary systemic amyloidosis; PRX003, indicated for the treatment of psoriasis and other inflammatory diseases. The company provides research and development services to other pharmaceutical and biotechnology companies. Prothena is headquartered in Dublin, Ireland.
Prothena Corp Plc (PRTA)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Prothena Corp Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Prothena Corp Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Prothena Corp Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Prothena Corp Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Prothena Corp Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Prothena Corp Plc, Medical Equipment, Deal Details 10
Partnerships 10
MJFF Enters into Agreement with Prothena 10
Equity Offering 10
Prothena Raises USD155.3 Million in Public Offering of Shares 10
Prothena Completes Public Offering Of Shares For US$92 Million 12
Prothena Corp Plc-Key Competitors 14
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Feb 14, 2017: Prothena Reports Fourth Quarter and Full Year 2016 Financial Results, and Provides Financial Guidance and R&D Update 17
Nov 01, 2016: Prothena Reports Third Quarter 2016 Financial Results and Provides R&D Update 20
Aug 02, 2016: Prothena Reports Second Quarter 2016 Financial Results; Provides R&D Update 22
May 03, 2016: Prothena Reports First Quarter 2016 Financial Results and Provides R&D Update 24
Feb 18, 2016: Prothena Reports Fourth Quarter and Full Year 2015 Financial Results; Provides Financial Guidance and R&D Update 26
Corporate Communications 28
Dec 15, 2016: Prothena Announces Appointment of Chief Regulatory Officer 28
Oct 03, 2016: Prothena Announces Appointment of Dr. Gene G. Kinney as President, Chief Executive Officer and Director 29
Sep 06, 2016: Prothena Announces Appointment of Gene G. Kinney as Chief Operating Officer 30
Feb 24, 2016: Prothena Announces Appointment of Chief Commercial Officer 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Figure
List of Figures
Prothena Corp Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Prothena Corp Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Prothena Corp Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Prothena Corp Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Prothena Corp Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Prothena Corp Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Prothena Corp Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Prothena Corp Plc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8
List of Table
List of Tables
Prothena Corp Plc, Medical Equipment, Key Facts, 2015 1
Prothena Corp Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Prothena Corp Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Prothena Corp Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Prothena Corp Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Prothena Corp Plc, Deals By Market, 2011 to YTD 2017 8
Prothena Corp Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
MJFF Enters into Agreement with Prothena 10
Prothena Raises USD155.3 Million in Public Offering of Shares 10
Prothena Completes Public Offering Of Shares For US$92 Million 12
Prothena Corp Plc, Key Competitors 14
Prothena Corp Plc, Key Employees 15
Prothena Corp Plc, Subsidiaries 16
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.